United States Microscopic Polyangiitis (MPA) Treatment Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Microscopic Polyangiitis (MPA) Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Microscopic Polyangiitis (MPA) Treatment Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Microscopic Polyangiitis (MPA) Treatment Overall Market Size
2.1 United States Microscopic Polyangiitis (MPA) Treatment Market Size: 2021 VS 2027
2.2 United States Microscopic Polyangiitis (MPA) Treatment Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Microscopic Polyangiitis (MPA) Treatment Players in United States Market
3.2 Top United States Microscopic Polyangiitis (MPA) Treatment Companies Ranked by Revenue
3.3 United States Microscopic Polyangiitis (MPA) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Microscopic Polyangiitis (MPA) Treatment Companies in United States Market, by Revenue in 2020
3.5 Companies Microscopic Polyangiitis (MPA) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Microscopic Polyangiitis (MPA) Treatment Players in United States Market
3.6.1 List of Tier 1 Microscopic Polyangiitis (MPA) Treatment Companies in United States
3.6.2 List of Tier 2 and Tier 3 Microscopic Polyangiitis (MPA) Treatment Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Microscopic Polyangiitis (MPA) Treatment Market Size Markets, 2021 & 2027
4.1.2 Avacopan
4.1.3 Immune Globulin
4.1.4 Rituximab Biosimilar
4.1.5 Others
4.2 By Type - United States Microscopic Polyangiitis (MPA) Treatment Revenue & Forecasts
4.2.1 By Type - United States Microscopic Polyangiitis (MPA) Treatment Revenue, 2016-2021
4.2.2 By Type - United States Microscopic Polyangiitis (MPA) Treatment Revenue, 2022-2027
4.2.3 By Type - United States Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Microscopic Polyangiitis (MPA) Treatment Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - United States Microscopic Polyangiitis (MPA) Treatment Revenue & Forecasts
5.2.1 By Application - United States Microscopic Polyangiitis (MPA) Treatment Revenue, 2016-2021
5.2.2 By Application - United States Microscopic Polyangiitis (MPA) Treatment Revenue, 2022-2027
5.2.3 By Application - United States Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2016-2027
6 Microscopic Polyangiitis (MPA) Treatment Companies Profiles
6.1 Celltrion Inc
6.1.1 Celltrion Inc Company Details
6.1.2 Celltrion Inc Business Overview
6.1.3 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Introduction
6.1.4 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Revenue in United States Market (2016-2021)
6.1.5 Celltrion Inc Recent Developments
6.2 ChemoCentryx Inc
6.2.1 ChemoCentryx Inc Company Details
6.2.2 ChemoCentryx Inc Business Overview
6.2.3 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Introduction
6.2.4 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Revenue in United States Market (2016-2021)
6.2.5 ChemoCentryx Inc Recent Developments
6.3 Sandoz International GmbH
6.3.1 Sandoz International GmbH Company Details
6.3.2 Sandoz International GmbH Business Overview
6.3.3 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Introduction
6.3.4 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Revenue in United States Market (2016-2021)
6.3.5 Sandoz International GmbH Recent Developments
6.4 Teijin Pharma Ltd
6.4.1 Teijin Pharma Ltd Company Details
6.4.2 Teijin Pharma Ltd Business Overview
6.4.3 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Introduction
6.4.4 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Revenue in United States Market (2016-2021)
6.4.5 Teijin Pharma Ltd Recent Developments
6.5 TTY Biopharm Company Ltd
6.5.1 TTY Biopharm Company Ltd Company Details
6.5.2 TTY Biopharm Company Ltd Business Overview
6.5.3 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Introduction
6.5.4 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Revenue in United States Market (2016-2021)
6.5.5 TTY Biopharm Company Ltd Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Microscopic Polyangiitis (MPA) Treatment Market Opportunities & Trends in United States Market
Table 2. Microscopic Polyangiitis (MPA) Treatment Market Drivers in United States Market
Table 3. Microscopic Polyangiitis (MPA) Treatment Market Restraints in United States Market
Table 4. Key Players of Microscopic Polyangiitis (MPA) Treatment in United States Market
Table 5. Top Microscopic Polyangiitis (MPA) Treatment Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Microscopic Polyangiitis (MPA) Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Microscopic Polyangiitis (MPA) Treatment Revenue Share by Companies, 2016-2021
Table 8. Companies Microscopic Polyangiitis (MPA) Treatment Product Type
Table 9. List of Tier 1 Microscopic Polyangiitis (MPA) Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Microscopic Polyangiitis (MPA) Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Microscopic Polyangiitis (MPA) Treatment Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Microscopic Polyangiitis (MPA) Treatment Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Microscopic Polyangiitis (MPA) Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Microscopic Polyangiitis (MPA) Treatment Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Microscopic Polyangiitis (MPA) Treatment Revenue (US$, Mn), 2022-2027
Table 17. Celltrion Inc Company Details
Table 18. Celltrion Inc Business Overview
Table 19. Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Product
Table 20. Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Celltrion Inc Recent Developments
Table 22. ChemoCentryx Inc Company Details
Table 23. ChemoCentryx Inc Business Overview
Table 24. ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Product
Table 25. ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. ChemoCentryx Inc Recent Developments
Table 27. Sandoz International GmbH Company Details
Table 28. Sandoz International GmbH Business Overview
Table 29. Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Product
Table 30. Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Sandoz International GmbH Recent Developments
Table 32. Teijin Pharma Ltd Company Details
Table 33. Teijin Pharma Ltd Business Overview
Table 34. Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Product
Table 35. Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Teijin Pharma Ltd Recent Developments
Table 37. TTY Biopharm Company Ltd Company Details
Table 38. TTY Biopharm Company Ltd Business Overview
Table 39. TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Product
Table 40. TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. TTY Biopharm Company Ltd Recent Developments
List of FiguresFigure 1. Microscopic Polyangiitis (MPA) Treatment Segment by Type
Figure 2. Microscopic Polyangiitis (MPA) Treatment Segment by Application
Figure 3. United States Microscopic Polyangiitis (MPA) Treatment Market Overview: 2020
Figure 4. United States Microscopic Polyangiitis (MPA) Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Microscopic Polyangiitis (MPA) Treatment Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Microscopic Polyangiitis (MPA) Treatment Revenue in 2020
Figure 7. By Type - United States Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2016-2027
Figure 8. By Application - United States Microscopic Polyangiitis (MPA) Treatment Revenue Market Share, 2016-2027
Figure 9. Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)